Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04547023 · ClinicalTrials.gov registry record · NA
Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy
A NA study of Gestational Diabetes and Pregnancy in Diabetic, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04547023 is a NA study of Gestational Diabetes and Pregnancy in Diabetic that has completed, run by Stanford University. The registered enrollment target is 200 participants, below the 317-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04547023, a NA study of Gestational Diabetes and Pregnancy in Diabetic, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Studies suggest that the timing interval between oral intake and the 1-hour gestational diabetes screen may have a significant impact on gestational diabetes screening glucose levels. The investigators plan to conduct a prospective randomized trial comparing a 6-hour fast versus liberal oral intake within 2 hours prior to the glucose tolerance test in pregnancy in order to evaluate the effect of the fasting versus the fed state on routine gestational diabetes screening results.
Conditions Studied
Interventions
- BEHAVIORAL Fasting before gestational diabetes screen
- BEHAVIORAL Per oral intake of food and drink
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04547023
The ClinicalTrials.gov registry entry for NCT04547023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 317-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (37% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Fasting before gestational diabetes screen is the first listed.
NCT04547023 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04547023 about?
NCT04547023 is a clinical study titled "Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy". Studies suggest that the timing interval between oral intake and the 1-hour gestational diabetes screen may have a significant impact on gestational diabetes screening glucose levels. The investigators plan to conduct a prospective randomized trial comparing a 6-hour fast versus liberal oral intake ...
What is the current status of trial NCT04547023?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2020-11-02. Estimated completion is 2021-11-01.
What conditions does trial NCT04547023 study?
This clinical trial studies the following conditions: Gestational Diabetes, Pregnancy in Diabetic, Glucose, High Blood, Diagnoses Disease.
What interventions are being tested in trial NCT04547023?
The interventions under investigation include: Fasting before gestational diabetes screen (BEHAVIORAL), Per oral intake of food and drink (BEHAVIORAL).
Who is sponsoring clinical trial NCT04547023?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04547023 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.